St. Luke’s receives accreditation for Integrated Cancer Program
St. Luke’s University Health Network has received another three-year Accreditation with Commendation as an Integrated Network Cancer Program (INCP) from the Commission on Cancer of the Chicago-based American College of Surgeons (CoC). The Network also received Accreditation with Commendation in 2004, 2007, 2010 and 2013.
To receive the voluntary CoC accreditation, a cancer program must meet or exceed 34 CoC quality standards, be evaluated every three years through a survey process and maintain levels of excellence in the delivery of comprehensive patient-centered care. The Commendation component is only awarded to a facility that exceeds standard requirements in several categories at the time of the triennial survey.
The survey, conducted last October, noted excellence in multiple categories that included accuracy of data and public reporting of outcomes. Commendation in five of the 34 categories means St. Luke’s received silver commendation status, a challenging accomplishment.
CoC surveyors noted that St. Luke’s is a “high-quality program … that provides excellent service, particularly in genetics, palliative care and clinical research, including immunotherapy.
“Overall,” the survey report stated, “St. Luke’s has an exceptional program with exceptional people.”
“I am very proud of our team,” said Joe Pinto, Vice President, Network Operations, St. Luke’s University Health Network.
“We are extremely honored to receive approval with commendation from the CoC,” said Lee B. Riley, MD, PhD, FACS, Medical Director, Oncology Clinical Integration, St. Luke’s University Health Network.